ID	4F63A	STANDARD;	PRT;	309	AA.
DT	CONVERTED FROM PDB (SEQRES) 4F63
DE	Fibroblast growth factor receptor 1
OS	Homo sapiens
CC	EXPDTA	X-RAY DIFFRACTION
CC	RESOLU	2.550
CC	R-Factor	0.232
FT	#SUB	246	 702 	PRO	A	248	 704 	VAL	B	Protein	B	1
FT	#SUB	246	 702 	PRO	A	261	 717 	HIS	B	Protein	S	2
FT	#SUB	247	 703 	GLY	A	248	 704 	VAL	B	Protein	B	5
FT	#SUB	247	 703 	GLY	A	249	 705 	PRO	B	Protein	B	1
FT	#SUB	247	 703 	GLY	A	252	 708 	GLU	B	Protein	B	3
FT	#SUB	248	 704 	VAL	A	246	 702 	PRO	B	Protein	S	1
FT	#SUB	248	 704 	VAL	A	247	 703 	GLY	B	Protein	S	1
FT	#SUB	248	 704 	VAL	A	248	 704 	VAL	B	Protein	S	2
FT	#SUB	249	 705 	PRO	A	247	 703 	GLY	B	Protein	S	1
FT	#SUB	249	 705 	PRO	A	249	 705 	PRO	B	Protein	S	1
FT	#SUB	252	 708 	GLU	A	247	 703 	GLY	B	Protein	S	4
FT	#SUB	256	 712 	LEU	A	247	 703 	GLY	B	Protein	S	1
FT	#SUB	261	 717 	HIS	A	246	 702 	PRO	B	Protein	S	2
FT	#SUB	265	 721 	LYS	A	267	 723 	SER	B	Protein	B	2
FT	#SUB	267	 723 	SER	A	265	 721 	LYS	B	Protein	S	4
FT	#SUB	267	 723 	SER	A	266	 722 	PRO	B	Protein	S	1
FT	#HET	28	 484 	LEU	A	1	801 	0S7	A	A	13
FT	#HET	29	 485 	GLY	A	1	801 	0S7	A	B	2
FT	#HET	36	 492 	VAL	A	1	801 	0S7	A	S	2
FT	#HET	56	 512 	ALA	A	1	801 	0S7	A	S	3
FT	#HET	75	 531 	GLU	A	2	802 	EDO	A	S	6
FT	#HET	79	 535 	MET	A	2	802 	EDO	A	S	2
FT	#HET	105	 561 	VAL	A	1	801 	0S7	A	S	1
FT	#HET	106	 562 	GLU	A	1	801 	0S7	A	B	4
FT	#HET	107	 563 	TYR	A	1	801 	0S7	A	A	5
FT	#HET	108	 564 	ALA	A	1	801 	0S7	A	A	12
FT	#HET	109	 565 	SER	A	1	801 	0S7	A	B	3
FT	#HET	111	 567 	GLY	A	1	801 	0S7	A	B	2
FT	#HET	174	 630 	LEU	A	1	801 	0S7	A	S	5
FT	#HET	184	 640 	ALA	A	2	802 	EDO	A	B	2
FT	#HET	185	 641 	ASP	A	1	801 	0S7	A	S	2
FT	#HET	185	 641 	ASP	A	2	802 	EDO	A	B	8
FT	#HET	186	 642 	PHE	A	2	802 	EDO	A	A	4
FT	#HET	187	 643 	GLY	A	2	802 	EDO	A	B	3
FT	#HET	228	 684 	TRP	A	3	803 	EDO	A	S	3
FT	#HET	245	 701 	TYR	A	3	803 	EDO	A	S	5
FT	#HET	261	 717 	HIS	A	3	803 	EDO	A	B	1
FT	#HET	262	 718 	ARG	A	3	803 	EDO	A	A	4
FT	#HET	263	 719 	MET	A	3	803 	EDO	A	A	4
FT	#HET	281	 737 	TRP	A	3	803 	EDO	A	S	8
FT	DISORDER	1	7
FT	DISORDER	30	34
FT	DISORDER	45	48
FT	DISORDER	124	135
FT	DISORDER	307	309
CC	Miss-BB	1
CC	Miss-SC	1
CC	SEQUENCE	278 AA (ATOM);
CC	ELPEDPRWEL PRDRLVLGKP LGQVVLAEAI GLPNRVTKVA VKMLKSDATE KDLSDLISEM
CC	EMMKMIGKHK NIINLLGACT QDGPLYVIVE YASKGNLREY LQARRPPEEQ LSSKDLVSCA
CC	YQVARGMEYL ASKKCIHRDL AARNVLVTED NVMKIADFGL ARDIHHIDYY KKTTNGRLPV
CC	KWMAPEALFD RIYTHQSDVW SFGVLLWEIF TLGGSPYPGV PVEELFKLLK EGHRMDKPSN
CC	CTNELYMMMR DCWHAVPSQR PTFKQLVEDL DRIVALTS
CC	!----
CC	ALIGNMENT OF SEQRES AND ATOMRES
CC	SEQRES GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPN
CC	ATOM   -------ELPEDPRWELPRDRLVLGKPLG-----QVVLAEAIGL----PN
CC	              **********************     **********    **
CC	SEQRES RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP
CC	ATOM   RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP
CC	       **************************************************
CC	SEQRES LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ
CC	ATOM   LYVIVEYASKGNLREYLQARRPP------------EEQLSSKDLVSCAYQ
CC	       ***********************            ***************
CC	SEQRES VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK
CC	ATOM   VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK
CC	       **************************************************
CC	SEQRES TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV
CC	ATOM   TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV
CC	       **************************************************
CC	SEQRES EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR
CC	ATOM   EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR
CC	       **************************************************
CC	SEQRES IVALTSNQE
CC	ATOM   IVALTS---
CC	       ******   
SQ	SEQUENCE	309 AA;      MW;         CN;
	GAGVSEYELP EDPRWELPRD RLVLGKPLGE GAFGQVVLAE AIGLDKDKPN RVTKVAVKML
	KSDATEKDLS DLISEMEMMK MIGKHKNIIN LLGACTQDGP LYVIVEYASK GNLREYLQAR
	RPPGLEYSYN PSHNPEEQLS SKDLVSCAYQ VARGMEYLAS KKCIHRDLAA RNVLVTEDNV
	MKIADFGLAR DIHHIDYYKK TTNGRLPVKW MAPEALFDRI YTHQSDVWSF GVLLWEIFTL
	GGSPYPGVPV EELFKLLKEG HRMDKPSNCT NELYMMMRDC WHAVPSQRPT FKQLVEDLDR
	IVALTSNQE
//
ID	4F63B	STANDARD;	PRT;	309	AA.
DT	CONVERTED FROM PDB (SEQRES) 4F63
DE	Fibroblast growth factor receptor 1
OS	Homo sapiens
CC	EXPDTA	X-RAY DIFFRACTION
CC	RESOLU	2.550
CC	R-Factor	0.232
FT	#SUB	246	 702 	PRO	B	248	 704 	VAL	A	Protein	B	1
FT	#SUB	246	 702 	PRO	B	261	 717 	HIS	A	Protein	S	2
FT	#SUB	247	 703 	GLY	B	248	 704 	VAL	A	Protein	B	1
FT	#SUB	247	 703 	GLY	B	249	 705 	PRO	A	Protein	B	1
FT	#SUB	247	 703 	GLY	B	252	 708 	GLU	A	Protein	B	4
FT	#SUB	247	 703 	GLY	B	256	 712 	LEU	A	Protein	B	1
FT	#SUB	248	 704 	VAL	B	246	 702 	PRO	A	Protein	S	1
FT	#SUB	248	 704 	VAL	B	247	 703 	GLY	A	Protein	A	5
FT	#SUB	248	 704 	VAL	B	248	 704 	VAL	A	Protein	A	2
FT	#SUB	249	 705 	PRO	B	247	 703 	GLY	A	Protein	S	1
FT	#SUB	249	 705 	PRO	B	249	 705 	PRO	A	Protein	S	1
FT	#SUB	252	 708 	GLU	B	247	 703 	GLY	A	Protein	S	3
FT	#SUB	261	 717 	HIS	B	246	 702 	PRO	A	Protein	S	2
FT	#SUB	265	 721 	LYS	B	267	 723 	SER	A	Protein	A	4
FT	#SUB	266	 722 	PRO	B	267	 723 	SER	A	Protein	B	1
FT	#SUB	267	 723 	SER	B	265	 721 	LYS	A	Protein	S	2
FT	#HET	28	 484 	LEU	B	4	801 	0S7	B	A	4
FT	#HET	56	 512 	ALA	B	4	801 	0S7	B	S	4
FT	#HET	75	 531 	GLU	B	5	802 	EDO	B	S	4
FT	#HET	79	 535 	MET	B	5	802 	EDO	B	S	1
FT	#HET	89	 545 	ILE	B	5	802 	EDO	B	S	2
FT	#HET	105	 561 	VAL	B	4	801 	0S7	B	S	1
FT	#HET	106	 562 	GLU	B	4	801 	0S7	B	B	4
FT	#HET	107	 563 	TYR	B	4	801 	0S7	B	A	4
FT	#HET	108	 564 	ALA	B	4	801 	0S7	B	A	7
FT	#HET	109	 565 	SER	B	4	801 	0S7	B	B	2
FT	#HET	111	 567 	GLY	B	4	801 	0S7	B	B	2
FT	#HET	171	 627 	ARG	B	4	801 	0S7	B	B	1
FT	#HET	172	 628 	ASN	B	4	801 	0S7	B	S	1
FT	#HET	174	 630 	LEU	B	4	801 	0S7	B	S	8
FT	#HET	184	 640 	ALA	B	4	801 	0S7	B	S	1
FT	#HET	185	 641 	ASP	B	4	801 	0S7	B	S	5
FT	#HET	185	 641 	ASP	B	5	802 	EDO	B	B	8
FT	#HET	186	 642 	PHE	B	5	802 	EDO	B	A	4
FT	#HET	187	 643 	GLY	B	5	802 	EDO	B	B	2
FT	#HET	228	 684 	TRP	B	6	803 	EDO	B	S	2
FT	#HET	245	 701 	TYR	B	6	803 	EDO	B	S	7
FT	#HET	257	 713 	LEU	B	6	803 	EDO	B	S	1
FT	#HET	261	 717 	HIS	B	6	803 	EDO	B	B	1
FT	#HET	262	 718 	ARG	B	6	803 	EDO	B	B	2
FT	#HET	263	 719 	MET	B	6	803 	EDO	B	A	2
FT	#HET	281	 737 	TRP	B	6	803 	EDO	B	S	8
FT	DISORDER	1	4
FT	DISORDER	33	33
FT	DISORDER	45	48
FT	DISORDER	122	137
FT	DISORDER	190	195
FT	DISORDER	201	203
FT	DISORDER	306	309
CC	SEQUENCE	271 AA (ATOM);
CC	SEYELPEDPR WELPRDRLVL GKPLGEGAGQ VVLAEAIGLP NRVTKVAVKM LKSDATEKDL
CC	SDLISEMEMM KMIGKHKNII NLLGACTQDG PLYVIVEYAS KGNLREYLQA RRQLSSKDLV
CC	SCAYQVARGM EYLASKKCIH RDLAARNVLV TEDNVMKIAD FGLADYYKKG RLPVKWMAPE
CC	ALFDRIYTHQ SDVWSFGVLL WEIFTLGGSP YPGVPVEELF KLLKEGHRMD KPSNCTNELY
CC	MMMRDCWHAV PSQRPTFKQL VEDLDRIVAL T
CC	!----
CC	ALIGNMENT OF SEQRES AND ATOMRES
CC	SEQRES GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPN
CC	ATOM   ----SEYELPEDPRWELPRDRLVLGKPLGEGA-GQVVLAEAIGL----PN
CC	           **************************** ***********    **
CC	SEQRES RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP
CC	ATOM   RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP
CC	       **************************************************
CC	SEQRES LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ
CC	ATOM   LYVIVEYASKGNLREYLQARR----------------QLSSKDLVSCAYQ
CC	       *********************                *************
CC	SEQRES VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK
CC	ATOM   VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------DYYKK
CC	       ***************************************      *****
CC	SEQRES TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV
CC	ATOM   ---GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV
CC	          ***********************************************
CC	SEQRES EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR
CC	ATOM   EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR
CC	       **************************************************
CC	SEQRES IVALTSNQE
CC	ATOM   IVALT----
CC	       *****    
SQ	SEQUENCE	309 AA;      MW;         CN;
	GAGVSEYELP EDPRWELPRD RLVLGKPLGE GAFGQVVLAE AIGLDKDKPN RVTKVAVKML
	KSDATEKDLS DLISEMEMMK MIGKHKNIIN LLGACTQDGP LYVIVEYASK GNLREYLQAR
	RPPGLEYSYN PSHNPEEQLS SKDLVSCAYQ VARGMEYLAS KKCIHRDLAA RNVLVTEDNV
	MKIADFGLAR DIHHIDYYKK TTNGRLPVKW MAPEALFDRI YTHQSDVWSF GVLLWEIFTL
	GGSPYPGVPV EELFKLLKEG HRMDKPSNCT NELYMMMRDC WHAVPSQRPT FKQLVEDLDR
	IVALTSNQE
//